Literature DB >> 24739683

Virtual Bronchoscopy Using OsiriX.

Atsushi Sano1, Takehiro Tsuchiya.   

Abstract

BACKGROUND: Although the utility of virtual bronchoscopy has been reported, the software for virtual bronchoscopy has not been popular because of the high cost. OsiriX is a reasonably priced software that is available to reconstruct virtual endoscopic images. Herein, we present the ability of OsiriX to enable virtual bronchoscopy.
METHODS: Computed tomography of the chest was performed using a 16-row multidetector. Data in 2 mm slices from one lung were obtained from 10 patients with a lung nodule. Virtual bronchoscopic images were established by OsiriX version 5.5 (32-bit). To examine the ability to visualize small bronchi, we tried to visualize the distal bronchus if possible. We selected B and B for the right lung and B and B for the left lung. In addition, to predict whether a pathologic diagnosis can successfully be made by transbronchial lung biopsy, we reconstructed virtual bronchoscopic images toward the lung nodule.
RESULTS: Bronchoscopic images were successfully reconstructed for all patients. The third to the seventh bronchi were visualized except in one patient whose right B was occluded by a tumor. In all patients, the virtual bronchoscopic path reached the lung nodule, and 5 lung nodules were successfully diagnosed by transbronchial biopsy.
CONCLUSIONS: OsiriX is practicable for virtual bronchoscopy at a low cost.

Entities:  

Mesh:

Year:  2014        PMID: 24739683     DOI: 10.1097/LBR.0000000000000051

Source DB:  PubMed          Journal:  J Bronchology Interv Pulmonol        ISSN: 1948-8270


  2 in total

1.  Virtual bronchoscopy using Horos.

Authors:  Atsushi Sano
Journal:  Lung India       Date:  2020 Sep-Oct

2.  Multiple guided technologies based on radial probe endobronchial ultrasound for the diagnosis of solitary peripheral pulmonary lesions: a single-center study.

Authors:  Huang Haidong; Ning Yunye; Zhang Wei; Paul Zarogoulidis; Wolfgang Hohenforst-Schmidt; Yan-Gao Man; Yang Yuguang; Dong Yuchao; Bai Chong
Journal:  J Cancer       Date:  2017-09-29       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.